| Nome |
# |
|
Effects of Thyroid Hormones and their Metabolites on Learning and Memory in Normal and Pathological Conditions, file e0d6c92a-e8c8-fcf8-e053-d805fe0aa794
|
452
|
|
Dual inhibition of PDK1 and Aurora Kinase A: an effective strategy to induce differentiation and apoptosis of human glioblastoma multiforme stem cells, file e0d6c92e-f6de-fcf8-e053-d805fe0aa794
|
284
|
|
New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection, file e0d6c929-caba-fcf8-e053-d805fe0aa794
|
175
|
|
Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3-iodothyronamine, file e0d6c929-16d3-fcf8-e053-d805fe0aa794
|
128
|
|
Metabolic reprogramming by 3-Iodothyronamine (T1AM): a new perspective to reverse obesity through co-regulation of sirtuin 4 and 6 expression, file e0d6c92a-f08e-fcf8-e053-d805fe0aa794
|
117
|
|
New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective, file e0d6c92b-35e4-fcf8-e053-d805fe0aa794
|
90
|
|
Memantine prodrug as a new agent for alzheimer’s disease, file e0d6c92d-6558-fcf8-e053-d805fe0aa794
|
73
|
|
The pleiotropic functionality of endogenous 3-iodothyronamine (T1AM) and synthetic thyronamine-like analogs: a powerful tool to target interlinked diseases such as obesity and neurodegeneration, file a5e0d36a-d6b8-4307-aef2-9bbb2653aafe
|
57
|
|
Modulation of Gene Expression by 3-Iodothyronamine: Genetic Evidence for a Lipolytic Pattern, file e0d6c92a-553d-fcf8-e053-d805fe0aa794
|
46
|
|
null, file e0d6c92d-d330-fcf8-e053-d805fe0aa794
|
44
|
|
Metabolic Reprogramming in Health and Disease, file e0d6c92e-e75d-fcf8-e053-d805fe0aa794
|
16
|
|
Thyronamines and Analogues - The Route from Rediscovery to Translational Research on Thyronergic Amines, file e0d6c92a-917d-fcf8-e053-d805fe0aa794
|
12
|
|
Screening of selective inhibitors of 1a,25-dihydroxyvitamin D3 24-hydroxylase using recombinant human enzyme expressed in Escherichia coli., file e0d6c928-10c0-fcf8-e053-d805fe0aa794
|
10
|
|
Update on 3-iodothyronamine and its neurological and metabolic actions, file e0d6c926-4b64-fcf8-e053-d805fe0aa794
|
8
|
|
null, file e0d6c927-1f67-fcf8-e053-d805fe0aa794
|
6
|
|
Endogenous 3-iodothyronamine (T1Am) and synthetic thyronamine-like analog SG-2 act as novel pleiotropic neuroprotective agents through the modulation of SIRT6, file e0d6c92e-cf97-fcf8-e053-d805fe0aa794
|
6
|
|
8.1.4 – Biological Vesicles and Platforms – Cyclodextrin-based platforms as RNA delivery systems, file d6d4748a-8c47-4b2c-8040-c50a1e3b98f9
|
5
|
|
Delivery of thyronamines (Tams) to the brain: A preliminary study, file e0d6c931-8682-fcf8-e053-d805fe0aa794
|
5
|
|
N-Cyclopropyl-(20R)-2-Methylene-19,26,27-trinor-25-aza-Vitamin D analogs and their uses, file e0d6c926-3fa1-fcf8-e053-d805fe0aa794
|
4
|
|
null, file e0d6c928-213e-fcf8-e053-d805fe0aa794
|
4
|
|
Synthesis and Biological Evaluation of Cyclopropylamine Vitamin D‐Like CYP24A1 Inhibitors, file e0d6c929-aaf4-fcf8-e053-d805fe0aa794
|
4
|
|
Recovery of 3-iodothyronamine and derivatives in biological matrices: problems and pitfalls, file e0d6c929-e9ed-fcf8-e053-d805fe0aa794
|
4
|
|
Uptake and metabolic effects of 3-iodothyronamine (T1AM) in hepatocytes, file e0d6c926-4110-fcf8-e053-d805fe0aa794
|
3
|
|
Synthetic analogues of 3-iodothyronamine (T1AM) and uses thereof., file e0d6c927-1956-fcf8-e053-d805fe0aa794
|
3
|
|
GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease., file e0d6c92a-e8c5-fcf8-e053-d805fe0aa794
|
3
|
|
SG-2: A promising lipolytic and pro-autophagic hit-compound to treat Alzheimer’s disease, file e0d6c92f-dd2e-fcf8-e053-d805fe0aa794
|
3
|
|
Understanding amyloid structures and disease: A continuing challenge in health research, file e0d6c931-4093-fcf8-e053-d805fe0aa794
|
3
|
|
Diphenyl-methane based thyromimetic inhibitors for transthyretin amyloidosis, file e0d6c931-4ba8-fcf8-e053-d805fe0aa794
|
3
|
|
null, file e0d6c931-8b9a-fcf8-e053-d805fe0aa794
|
3
|
|
Thyroxine metabolite-derived 3-iodothyronamine (T1AM) and synthetic analogs as efficient suppressors of transthyretin amyloidosis, file e69f051d-977f-49c2-8351-a3790b71531b
|
3
|
|
Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB2R), file 4df2cc93-2fae-4e84-93fa-a2e883a1120f
|
2
|
|
Optical imaging of mitochondrial redox state in rodent models with 3-iodothyronamine., file e0d6c926-4654-fcf8-e053-d805fe0aa794
|
2
|
|
Brain histamine modulates the antidepressant-like effect of the 3-iodothyroacetic acid (TA1), file e0d6c92d-89dd-fcf8-e053-d805fe0aa794
|
2
|
|
Ultrastructural Localization of Histidine-rich Glycoprotein in Skeletal Muscle Fibers: Colocalization With AMP Deaminase, file e0d6c92e-5e59-fcf8-e053-d805fe0aa794
|
2
|
|
Collecting data through high throughput in vitro early toxicity and off-target liability assays to rapidly identify limitations of novel thyromimetics, file e0d6c92f-8eeb-fcf8-e053-d805fe0aa794
|
2
|
|
3-iodothyronamine affects thermogenic substrates’ mobilization in brown adipocytes, file e0d6c92f-ac46-fcf8-e053-d805fe0aa794
|
2
|
|
Potential role of two novel agonists of thyroid hormone receptor-β on liver regeneration, file e0d6c92f-b20d-fcf8-e053-d805fe0aa794
|
2
|
|
Lipolytic effects of 3-iodothyronamine (T1AM) and a novel thyronamine-like analog SG-2 through the AMPK pathway, file e0d6c930-2967-fcf8-e053-d805fe0aa794
|
2
|
|
An Efficient Aequorea victoria Green Fluorescent Protein for Stimulated Emission Depletion Super-Resolution Microscopy, file e0d6c931-c9a5-fcf8-e053-d805fe0aa794
|
2
|
|
The role of cannabinoids in bone metabolism: A new perspective for bone disorders, file e0d6c932-06c4-fcf8-e053-d805fe0aa794
|
2
|
|
A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor, file e0d6c925-ea36-fcf8-e053-d805fe0aa794
|
1
|
|
Thyroid hormone-sympathetic interaction and adaptive thermogenesis are thyroid hormone receptor isoform-specific, file e0d6c925-eb97-fcf8-e053-d805fe0aa794
|
1
|
|
NMR-based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T1 AM treatment, file e0d6c926-3fa3-fcf8-e053-d805fe0aa794
|
1
|
|
26-Desmethyl-2-methylene-22-ene-19-nor-1 alpha,25-dihydroxyvitamin D-3 compounds selectively active on intestine, file e0d6c926-4322-fcf8-e053-d805fe0aa794
|
1
|
|
In the brain of mice, 3-iodothyronamine (T1AM) is converted into 3-iodothyroacetic acid (TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine, file e0d6c926-79c0-fcf8-e053-d805fe0aa794
|
1
|
|
Synthesis and biological activities of vitamin D-like inhibitors of CYP24 hydroxylase, file e0d6c929-2b79-fcf8-e053-d805fe0aa794
|
1
|
|
Cardioprotection by ranolazine in perfused rat heart, file e0d6c929-4f8c-fcf8-e053-d805fe0aa794
|
1
|
|
Tissue Distribution and Cardiac Metabolism of 3-Iodothyronamine, file e0d6c92a-116e-fcf8-e053-d805fe0aa794
|
1
|
|
3-Iodothyronamine metabolism and functional effects in FRTL5 thyroid cells., file e0d6c92a-4e92-fcf8-e053-d805fe0aa794
|
1
|
|
Editorial: Thyroid Hormone and Metabolites: Central Versus Peripheral Effects., file e0d6c92d-aa13-fcf8-e053-d805fe0aa794
|
1
|
|
Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis, file e0d6c92e-3e6c-fcf8-e053-d805fe0aa794
|
1
|
|
Transthyretin stabilization: An emerging strategy for the treatment of alzheimer’s disease?, file e0d6c92f-97eb-fcf8-e053-d805fe0aa794
|
1
|
|
null, file e0d6c930-6add-fcf8-e053-d805fe0aa794
|
1
|
|
null, file e0d6c930-cc12-fcf8-e053-d805fe0aa794
|
1
|
| Totale |
1.608 |